Medirom Capital Stock from 2010 to 2024

MRM Stock

USD 2.64 0.06 2.22%

Medirom Healthcare Capital Stock yearly trend continues to be very stable with very little volatility. Capital Stock is likely to drop to about 19 M. Capital Stock is the total amount of a company's capital funded by shareholders through the issue and subscription of shares. View All Fundamentals

Capital Stock

First Reported

2010-12-31

Previous Quarter

20 M

Current Value

19 M

Quarterly Volatility

421.9 M

Credit Downgrade

Yuan Drop

Covid

Check Medirom Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medirom Healthcare's main balance sheet or income statement drivers, such as Interest Income of 2 M, Depreciation And Amortization of 135.8 M or Interest Expense of 18.5 M, as well as many indicators such as Price To Sales Ratio of 0.58, Dividend Yield of 0.0 or PTB Ratio of 20.74. Medirom financial statements analysis is a perfect complement when working with Medirom Healthcare Valuation or Volatility modules.

Check out the analysis of Medirom Healthcare Correlation against competitors.

Latest Medirom Healthcare's Capital Stock Growth Pattern

Below is the plot of the Capital Stock of Medirom Healthcare Technologies over the last few years. It is the total amount of a company's capital funded by shareholders through the issue and subscription of shares. Medirom Healthcare's Capital Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Medirom Healthcare's overall financial position and show how it may be relating to other accounts over time.

Capital Stock

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Capital Stock

Timeline

Medirom Capital Stock Regression Statistics

	Arithmetic Mean	431,058,733
	Geometric Mean	255,275,943
	Coefficient Of Variation	97.88
	Mean Deviation	332,899,476
	Median	245,100,000
	Standard Deviation	421,901,689
	Sample Variance	178001T
	Range	1.2B
	R-Value	0.35
	Mean Square Error	167558.7T
	R-Squared	0.13
	Significance	0.19
	Slope	33,474,446
	Total Sum of Squares	2492014.5T

Medirom Capital Stock History

	2024	19 M
	2023	20 M
	2021	1.2 B
	2020	1.2 B
	2019	595.1 M

Other Fundumenentals of Medirom Healthcare

Issuance Of Capital Stock

Medirom Healthcare Capital Stock component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Good Will	Short Term Investments	Total Liab	Net Invested Capital	Long Term Investments	Short Long Term Debt	Total Current Assets	Capital Stock	Net Working Capital	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Deferred Long Term Liab
Total Assets		0.32	-0.71	-0.68	-0.14	-0.25	0.33	0.96	-0.32	0.89	-0.91	0.96	0.85	0.14	-0.33	0.9	0.38	-0.05	-0.6	0.85	0.38	-0.56	-0.58
Total Stockholder Equity	0.32		0.39	0.05	-0.56	0.12	-0.55	0.1	-0.43	0.03	-0.08	0.05	0.7	-0.67	-0.03	0.53	0.22	0.62	-0.3	0.19	0.22	-0.75	-0.23
Net Tangible Assets	-0.71	0.39		0.7	-0.38	0.24	-0.8	-0.8	-0.17	-0.86	0.82	-0.87	-0.32	-0.66	0.19	-0.42	-0.12	0.64	0.35	-0.75	-0.12	0.03	0.49
Current Deferred Revenue	-0.68	0.05	0.7		0.3	0.73	-0.75	-0.7	-0.01	-0.85	0.57	-0.73	-0.27	0.01	0.72	-0.67	-0.71	0.13	0.83	-0.45	-0.71	0.19	0.2
Net Debt	-0.14	-0.56	-0.38	0.3		0.51	0.34	-0.07	0.66	0.01	-0.15	0.01	-0.18	0.9	0.6	-0.53	-0.71	-0.87	0.67	0.23	-0.71	0.45	-0.19
Retained Earnings	-0.25	0.12	0.24	0.73	0.51		-0.47	-0.36	0.01	-0.48	0.0	-0.31	0.09	0.25	0.98	-0.39	-0.94	-0.28	0.56	0.19	-0.94	-0.23	-0.49
Accounts Payable	0.33	-0.55	-0.8	-0.75	0.34	-0.47		0.42	0.57	0.67	-0.43	0.51	-0.13	0.51	-0.37	0.12	0.26	-0.69	-0.33	0.34	0.26	0.31	-0.1
Long Term Debt	0.96	0.1	-0.8	-0.7	-0.07	-0.36	0.42		-0.31	0.9	-0.89	0.99	0.72	0.29	-0.42	0.84	0.41	-0.1	-0.53	0.76	0.41	-0.35	-0.45
Net Receivables	-0.32	-0.43	-0.17	-0.01	0.66	0.01	0.57	-0.31		0.04	0.21	-0.21	-0.41	0.46	0.13	-0.54	-0.21	-0.7	0.4	-0.11	-0.21	0.58	0.22
Good Will	0.89	0.03	-0.86	-0.85	0.01	-0.48	0.67	0.9	0.04		-0.79	0.93	0.59	0.29	-0.48	0.72	0.49	-0.28	-0.58	0.75	0.49	-0.27	-0.4
Short Term Investments	-0.91	-0.08	0.82	0.57	-0.15	0.0	-0.43	-0.89	0.21	-0.79		-0.93	-0.72	-0.41	0.06	-0.73	-0.04	0.35	0.44	-0.91	-0.04	0.45	0.73
Total Liab	0.96	0.05	-0.87	-0.73	0.01	-0.31	0.51	0.99	-0.21	0.93	-0.93		0.7	0.35	-0.35	0.8	0.34	-0.23	-0.55	0.83	0.34	-0.37	-0.54
Net Invested Capital	0.85	0.7	-0.32	-0.27	-0.18	0.09	-0.13	0.72	-0.41	0.59	-0.72	0.7		-0.05	-0.05	0.82	0.16	0.18	-0.35	0.74	0.16	-0.72	-0.58
Long Term Investments	0.14	-0.67	-0.66	0.01	0.9	0.25	0.51	0.29	0.46	0.29	-0.41	0.35	-0.05		0.34	-0.25	-0.49	-0.84	0.46	0.38	-0.49	0.45	-0.22
Short Long Term Debt	-0.33	-0.03	0.19	0.72	0.6	0.98	-0.37	-0.42	0.13	-0.48	0.06	-0.35	-0.05	0.34		-0.52	-0.97	-0.4	0.59	0.16	-0.97	-0.13	-0.46
Total Current Assets	0.9	0.53	-0.42	-0.67	-0.53	-0.39	0.12	0.84	-0.54	0.72	-0.73	0.8	0.82	-0.25	-0.52		0.59	0.32	-0.76	0.6	0.59	-0.64	-0.4
Capital Stock	0.38	0.22	-0.12	-0.71	-0.71	-0.94	0.26	0.41	-0.21	0.49	-0.04	0.34	0.16	-0.49	-0.97	0.59		0.5	-0.68	-0.1	1.0	-0.06	0.37
Net Working Capital	-0.05	0.62	0.64	0.13	-0.87	-0.28	-0.69	-0.1	-0.7	-0.28	0.35	-0.23	0.18	-0.84	-0.4	0.32	0.5		-0.25	-0.42	0.5	-0.31	0.37
Short Term Debt	-0.6	-0.3	0.35	0.83	0.67	0.56	-0.33	-0.53	0.4	-0.58	0.44	-0.55	-0.35	0.46	0.59	-0.76	-0.68	-0.25		-0.39	-0.68	0.59	0.34
Intangible Assets	0.85	0.19	-0.75	-0.45	0.23	0.19	0.34	0.76	-0.11	0.75	-0.91	0.83	0.74	0.38	0.16	0.6	-0.1	-0.42	-0.39		-0.1	-0.61	-0.89
Common Stock	0.38	0.22	-0.12	-0.71	-0.71	-0.94	0.26	0.41	-0.21	0.49	-0.04	0.34	0.16	-0.49	-0.97	0.59	1.0	0.5	-0.68	-0.1		-0.06	0.37
Property Plant Equipment	-0.56	-0.75	0.03	0.19	0.45	-0.23	0.31	-0.35	0.58	-0.27	0.45	-0.37	-0.72	0.45	-0.13	-0.64	-0.06	-0.31	0.59	-0.61	-0.06		0.74
Deferred Long Term Liab	-0.58	-0.23	0.49	0.2	-0.19	-0.49	-0.1	-0.45	0.22	-0.4	0.73	-0.54	-0.58	-0.22	-0.46	-0.4	0.37	0.37	0.34	-0.89	0.37	0.74

Click cells to compare fundamentals

About Medirom Healthcare Financial Statements

Medirom Healthcare investors utilize fundamental indicators, such as Capital Stock, to predict how Medirom Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.

		Last Reported	Projected for Next Year
	Capital Stock	20 M	19 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Medirom Healthcare is a strong investment it is important to analyze Medirom Healthcare's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Medirom Healthcare's future performance. For an informed investment choice regarding Medirom Stock, refer to the following important reports:

How To Invest In Medirom

Details

Is Medirom Stock a good investment?

Details

What is Medirom Healthcare's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out the analysis of Medirom Healthcare Correlation against competitors.

You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medirom Healthcare. If investors know Medirom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medirom Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.582

Earnings Share

(0.15)

Revenue Per Share

1.4 K

Quarterly Revenue Growth

(0.06)

Return On Assets

(0.04)

The market value of Medirom Healthcare is measured differently than its book value, which is the value of Medirom that is recorded on the company's balance sheet. Investors also form their own opinion of Medirom Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Medirom Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medirom Healthcare's market value can be influenced by many factors that don't directly affect Medirom Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Medirom Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Medirom Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medirom Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Medirom Capital Stock from 2010 to 2024

Latest Medirom Healthcare's Capital Stock Growth Pattern

Medirom Capital Stock Regression Statistics

Medirom Capital Stock History

Other Fundumenentals of Medirom Healthcare

Medirom Healthcare Capital Stock component correlations

About Medirom Healthcare Financial Statements

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY